Amphastar Pharmaceuticals (AMPH) Profit After Tax Growth (5y) (2018 - 2026)
Powered by 
Analysis
Amphastar Pharmaceuticals (AMPH) Profit After Tax Growth (5y) (2018 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn |
| 10 | RedHill Biopharma | 178.35 Mn | 178.35 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 31.33% |
| Mar 31, 2026 | 4.96% |
| Dec 31, 2025 | 42.59% |
| Sep 30, 2025 | 29.34% |
| Jun 30, 2025 | 154.96% |
| Mar 31, 2025 | 44.97% |
| Dec 31, 2024 | 108.07% |
| Sep 30, 2024 | 98.56% |
| Jun 30, 2024 | -4.51% |
| Mar 31, 2024 | 118.45% |
| Dec 31, 2023 | 81.40% |
| Sep 30, 2023 | 83.43% |
| Jun 30, 2023 | 62.00% |
| Mar 31, 2023 | 41.36% |
| Dec 31, 2022 | 112.34% |
| Sep 30, 2022 | 176.63% |
| Jun 30, 2022 | 55.63% |
| Mar 31, 2022 | 94.96% |
| Dec 31, 2021 | 56.15% |
| Sep 30, 2021 | 51.42% |